Clinical Evaluation of Stenfilcon A Contact Lenses

January 14, 2020 updated by: CooperVision, Inc.

Clinical Evaluation of CooperVision MyDay Lenses

This study is to evaluate the fitting performance of stenfilcon A contact lens (test) compared to narafilcon A contact lens (control).

Study Overview

Status

Completed

Conditions

Detailed Description

This study is to evaluate the fitting performance of stenfilcon A contact lens (test) compared to narafilcon A contact lens (control) over 3 hour of wear time in a Japanese population.

Study Type

Interventional

Enrollment (Actual)

40

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Fukusima
      • Fukushima, Fukusima, Japan, 960-8034
        • Shioya eye clinic
    • Kyoto
      • Terada, Kyoto, Japan, 610-0121
        • Kodama Eye Clinic
    • Tokyo
      • Shibuya, Tokyo, Japan, 15-0043
        • Itoi Eye Clinic
    • Yamaguchi
      • Shimonoseki, Yamaguchi, Japan, 751-0872
        • Ueda Eye Clinic

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

A person is eligible for inclusion in the study if he/she:

  • Is Japanese
  • Has had a self-reported oculo-visual examination in the last two years.
  • Is at least 18 years of age and has full legal capacity to volunteer.
  • Has read and understood the informed consent letter.
  • Is willing and able to follow instructions and maintain the appointment schedule.
  • Is correctable to a visual acuity of 20/40 or better (in each eye) with their habitual vision correction or 20/20 best-corrected.
  • Currently wears soft contact lenses.
  • Has clear corneas and no active ocular disease.

Exclusion Criteria:

A person will be excluded from the study if he/she:

  • Has never worn contact lenses before.
  • Has any systemic disease affecting ocular health.
  • Is using any systemic or topical medications that will affect ocular health.
  • Has any ocular pathology or severe insufficiency of lacrimal secretion (moderate to severe dry eyes) that would affect the wearing of contact lenses.
  • Has persistent, clinically significant corneal or conjunctival staining using sodium fluorescein dye.
  • Has any clinically significant lid or conjunctival abnormalities, active neovascularization or any central corneal scars.
  • Is aphakic.
  • Has undergone corneal refractive surgery.
  • Is participating in any other type of eye related clinical or research study.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: stenfilcon A lens
MyDay contact lens
contact lens
Other Names:
  • MyDay, test
Active Comparator: narafilcon A lens
1-Day Acuvue TruEye
contact lens
Other Names:
  • 1-day Acuvue TruEye, control

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Lens Movement
Time Frame: 5 minutes
Movement of lens after blink: (Categories = Tight, Slightly tight, Optimum, Slightly loose, Loose)
5 minutes
Lens Movement
Time Frame: 3hrs
Movement of lens after blink: (Categories = Tight, Slightly tight, Optimum, Slightly loose, Loose)
3hrs
Horizontal Lens Centration
Time Frame: 5 minutes
Centration of lens horizontally: (Grades = Temporal, Slightly temporal, Centered, Slightly Nasal, Nasal)
5 minutes
Horizontal Lens Centration
Time Frame: 3hrs
Centration of lens horizontally: (Grades = Temporal, Slightly temporal, Centered, Slightly Nasal, Nasal)
3hrs
Vertical Lens Centration
Time Frame: 5 minutes
Centration of lens horizontally: (Grades = Superior, Slightly superior, Center, Slightly inferior, Inferior)
5 minutes
Vertical Lens Centration
Time Frame: 3hrs
Centration of lens horizontally: (Grades = Superior, Slightly superior, Centered, Slightly inferior, Inferior)
3hrs
Corneal Coverage
Time Frame: 5 minutes
Does lens cover the cornea: (Yes, No)
5 minutes
Corneal Coverage
Time Frame: 3hrs
Does lens cover the cornea: (Yes, No)
3hrs
Lens Lag
Time Frame: 5 minutes
Movement after looking right and left: (Grades = Move along with cornea, slight delay, delay)
5 minutes
Lens Lag
Time Frame: 3hrs
Movement after looking right and left: (Grades = Move along with cornea, slight delay, delay)
3hrs
Overall Fitting Performance
Time Frame: 5 minutes
Lens fit performance: (Grades: Optimum, Good, Acceptable, Unacceptable)
5 minutes
Overall Fitting Performance
Time Frame: 3hrs
Lens fit performance: (Grades: Optimum, Good, Acceptable, Unacceptable)
3hrs
Investigator Fit Preference
Time Frame: 5 minutes
Lens fit preference: (Grades: Prefer stenfilcon A strongly, Prefer stenfilcon A slightly, Either, Prefer narafilcon A slightly, Prefer narafilcon A strongly)
5 minutes
Investigator Fit Preference
Time Frame: 3hrs
Lens fit preference: (Grades: Prefer stenfilcon A strongly, Prefer stenfilcon A slightly, Either, Prefer narafilcon A slightly, Prefer narafilcon A strongly)
3hrs

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Comfort
Time Frame: Baseline
Subjective comfort: (on a scale of 0-10, 0 (Uncomfortable) - 10 (Comfortable))
Baseline
Comfort
Time Frame: 5 Minutes
Subjective comfort: (on a scale of 0-10, 0 (Uncomfortable) - 10 (Comfortable))
5 Minutes
Comfort
Time Frame: 3 hours
Subjective comfort: (on a scale of 0-10, 0 (Uncomfortable) - 10 (Comfortable))
3 hours
Dryness
Time Frame: Baseline
Subjective dryness: (on a scale of 0-10, 0 (Dry) - 10 (Not dry))
Baseline
Dryness
Time Frame: 5 minutes
Subjective dryness: (on a scale of 0-10, 0 (Dry) - 10 (Not dry))
5 minutes
Dryness
Time Frame: 3 hours
Subjective dryness: (on a scale of 0-10, 0 (Dry) - 10 (Not dry))
3 hours
Stinging/Burning
Time Frame: Baseline
Subjective stinging/burning sensation: (on a scale of 0-10, 0 (Cannot wear) - 10 (No Stinging/Burning))
Baseline
Stinging/Burning
Time Frame: 5 minutes
Subjective stinging/burning sensation: (on a scale of 0-10, 0 (Cannot wear) - 10 (No Stinging/Burning))
5 minutes
Stinging/Burning
Time Frame: 3 hours
Subjective stinging/burning sensation: (on a scale of 0-10, 0 (Cannot wear) - 10 (No Stinging/Burning))
3 hours
Edge/Lens Awareness
Time Frame: Baseline
Subjective edge/lens awareness: (on a scale of 0-10, 0 (Cannot wear) - 10 (No edge awareness))
Baseline
Edge/Lens Awareness
Time Frame: 5 minutes
Subjective edge/lens awareness: (on a scale of 0-10, 0 (Cannot wear) - 10 (No edge awareness))
5 minutes
Edge/Lens Awareness
Time Frame: 3 hours
Subjective edge/lens awareness: (on a scale of 0-10, 0 (Cannot wear) - 10 (No edge awareness))
3 hours
Subjective Lens Preference
Time Frame: Baseline
Lens preference (stenfilcon A, Either, Neither, narafilcon A)
Baseline
Subjective Lens Preference
Time Frame: 5 minutes
Lens preference (stenfilcon A, Either, Neither, narafilcon A)
5 minutes
Subjective Lens Preference
Time Frame: 3 hours
Lens preference (stenfilcon A, Either, Neither, narafilcon A)
3 hours

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Yuji Kodama, MD, PhD, Kodama Eye Clinic

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

March 3, 2018

Primary Completion (Actual)

April 25, 2018

Study Completion (Actual)

April 25, 2018

Study Registration Dates

First Submitted

March 14, 2018

First Submitted That Met QC Criteria

March 19, 2018

First Posted (Actual)

March 21, 2018

Study Record Updates

Last Update Posted (Actual)

January 29, 2020

Last Update Submitted That Met QC Criteria

January 14, 2020

Last Verified

January 1, 2020

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • JP-MKTG-201709_02

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

Yes

product manufactured in and exported from the U.S.

Yes

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Myopia

Clinical Trials on stenfilcon A lens

Subscribe